Skip to main content

Want a detailed portfolio tracker?

Rani Therapeutics (RANI) P/E (2021 - 2026)

Rani Therapeutics (RANI) P/E from Sep 30, 2021 to Jul 21, 2026. The TTM Rani Therapeutics (RANI) P/E is -1.24. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Rani Therapeutics (RANI)

YearP/EChange
2026-1.24-30.76%
2025-1.80+49.53%
2024-1.20-49.96%
2023-2.40-55.68%
2022-5.41-94.65%
2021-101.21N/A

Comparison Rani Therapeutics (RANI) P/E with competitors

Rani Therapeutics (RANI) P/E is -1.24.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.14%
NBYStablecoin Development Corp0.00-100.35%
ENLVEnlivex Ltd0.07-106.02%
FGENFibroGen Inc0.24-119.30%
CHRSCoherus Biosciences Inc0.85-168.24%
FBIOFortress Biotech Inc0.95-176.32%
ORMPOramed Pharmaceuticals Inc1.50-220.88%
AGENAgenus Inc3.01-342.03%
INVAInnoviva Inc3.15-353.65%
VXRTVaxart Inc3.55-385.47%
CRMDCorMedix Inc3.63-391.80%
CVACCureVac N.V.4.45-457.52%
GLPGGalapagos NV4.86-490.75%
SRPTSarepta Therapeutics Inc4.88-492.62%
ABEOAbeona Therapeutics Inc5.39-533.26%
ABUSArbutus Biopharma Corp5.60-550.00%
ZVRAZevra Therapeutics Inc5.89-573.45%
SPROSpero Therapeutics Inc6.23-600.89%
CGENCompugen Ltd6.31-607.77%
RIGLRigel Pharmaceuticals6.87-652.65%
SLXNSilexion Therapeutics Corp7.30-686.75%
OMEROmeros Corporation9.26-844.59%
AUPHAurinia Pharmaceuticals Inc9.58-870.82%
PLXProtalix BioTherapeutics Inc10.89-975.85%
ACADAcadia Pharmaceuticals Inc11.73-1043.21%
TBPHTheravance Biopharma Inc12.26-1086.12%
ADMAAdma Biologics Inc12.42-1098.67%
HRMYHarmony Biosciences Holdings Inc13.82-1211.42%
SABSSAB Biotherapeutics Inc14.14-1236.84%
NAGENiagen Bioscience Inc14.82-1291.68%
INCYIncyte Corp15.82-1372.45%
REGNRegeneron Pharmaceuticals Inc15.86-1375.20%
PBYIPuma Biotechnology Inc17.32-1492.53%
CPRXCatalyst Pharmaceuticals Inc17.44-1502.47%
EXELExelixis Inc17.54-1510.41%
TGTXTG Therapeutics Inc18.97-1625.25%
MDXGMimedx Group Inc20.55-1752.84%
XOMAXOMA Royalty Corp22.87-1939.64%
ARGXArgen X SE24.30-2054.10%
CTMXCytomX Therapeutics Inc24.82-2096.17%
XOMAOXOMA Royalty Corp25.34-2138.29%
HALOHalozyme Therapeutics Inc25.62-2160.72%
XOMAPXOMA Royalty Corp25.67-2164.45%
VRTXVertex Pharmaceuticals Inc27.99-2351.40%
RPRXRoyalty Pharma plc - Class A28.69-2407.12%
SLNOSoleno Therapeutics Inc29.02-2433.48%
ASNDAscendis Pharma A/S30.09-2519.55%
LGNDLigand Pharmaceuticals Inc - Class B37.91-3148.97%
APLSApellis Pharmaceuticals Inc39.02-3238.18%
BMRNBiomarin Pharmaceutical Inc42.21-3494.78%
KRYSKrystal Biotech Inc45.34-3746.63%
ONCBeiGene Ltd69.54-5692.61%
PHARPharming Group N.V.75.03-6133.74%
TECHBio-Techne Corp101.96-8299.74%
VCELVericel Corp109.92-8940.14%
ALNYAlnylam Pharmaceuticals Inc117.96-9587.04%
GMABGenmab140.29-11382.52%
TLXTelix Pharmaceuticals Ltd162.15-13140.72%
CORTCorcept Therapeutics Inc212.86-17218.51%